Alzheimer's Drugs Market to Grow Rapidly by about 10% CAGR During 2024-2030 and Touch $5 billion by 2030
A new report from Industry Experts Inc, on "Alzheimer’s Drugs", is introduced. According to this study, global market for Alzheimer’s Drugs will likely maintain a robust CAGR of 9.9% during the 2024-2030 analysis period and reach a projected US$9.2 billion by 2030 from an estimated US$5.2 billion in 2024.
The rising prevalence of Alzheimer's disease, driven mainly by the aging population, is leading to the expansion of the Alzheimer's drugs market. With the increase in life expectancy, especially in developed countries, there is a growing number of people at risk for Alzheimer's disease, leading to a larger group of potential patients. Innovations in drug development, such as medications aimed at the root cause of illnesses, combined with increased awareness and early diagnoses, further drive this market growth.
North America leads the Alzheimer's drugs market with an estimated share of 38.9% in 2024, driven by a high prevalence of the disease, recent drug approvals, and advanced healthcare systems. The region benefits from major pharmaceutical companies conducting research and clinical trials alongside an aging population. Conversely, the Asia Pacific region is projected to be the fastest-growing market, with a CAGR of 11.5% during the analysis period 2024-2030.
Alzheimer's drugs market is analyzed in this report globally, covering the major regions including North America (The United States, Canada, and Mexico), Europe (Germany, France, the United Kingdom, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World.
The global market for Alzheimer's drugs studied in this report with respect to Drug Class – Cholinesterase Inhibitors, NMDA Receptor Antagonists, Combination Drugs and Others (Including Monoclonal Antibodies, Anti-amyloid Beta, Nutritional supplements, and Pipeline Drugs); Route of Administration – Oral, Injectable and Transdermal Patch; and Distribution Channel – Hospital Pharmacy, Retail Pharmacy and Online Pharmacy.
About Industry Experts, Inc
Industry Experts, Inc., ranks among the leading market research providers globally. The company's off-the-shelf and customized business intelligence reports offer strategic insights and valuable guidance to enable various stakeholders, such as corporate strategists, analysts, researchers and startups, among others, in obtaining valuable, crisp and unbiased current and future market data. For more information, contact us on +1-320-497-3787 or visit https://industry-experts.com/
Comments
Post a Comment